Abstract
Mouse L929 cells were incubated with antibody-targeted liposomes containing oligodeoxyribonucleotides (oligomers). When the oligomer was a 15-mer complementary to the 5'-end region of the mRNA encoding the N protein of vesicular stomatitis virus, the cells became less permissive for multiplication of that virus; greater than 95% reduction of viral multiplication was achieved. Protection was not seen for "empty" liposomes, liposomes containing a random oligomer sequence, or liposomes containing a sequence complementary to the 5' end of c-myc protooncogene mRNA targeted by the same antibody, nor was it seen when the liposomes containing the N-protein antisense oligomer were targeted by an antibody that does not bind to L929 cells. Antibody-bearing liposomes containing antisense oligomers thus have a double specificity: a particular cell selected by the targeting antibody on the liposome and a particular mRNA in the cell selected by sequence complementarity with the liposome-encapsulated oligomer. Nonencapsulated oligomers are sensitive to nucleases and usually must be administered to cells at high concentrations. Oligomers encapsulated in liposomes resist DNase and are active in amounts 1-2 orders of magnitude lower than for those reported for unencapsulated oligomer sequences.
MeSH Terms
1,2-Dipalmitoylphosphatidylcholine
Animals
Antibodies, Monoclonal
Antiviral Agents
Base Sequence
Kinetics
L Cells
Liposomes
Mice
Molecular Sequence Data
Oligodeoxyribonucleotides/pharmacology
Oligonucleotide Probes/chemical synthesis
RNA, Viral/genetics
Vesicular stomatitis Indiana virus/drug effects,genetics,physiology
Viral Proteins/biosynthesis,isolation & purification
Virus Replication/drug effects
Chemicals
Antibodies, Monoclonal
Antiviral Agents
Liposomes
Oligodeoxyribonucleotides
Oligonucleotide Probes
RNA, Viral
Viral Proteins
1,2-Dipalmitoylphosphatidylcholine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Leonetti J P
Laboratoire de Biochimie des Protéines, Université des Sciences et Techniques du Languedoc, Montpellier, France.
Machy P
Degols G
Lebleu B
Leserman L
References (19)
19 references, click to expand
-
Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours.
EMBO J. 1983;2(12):2375-83
PMID: 6321164
-
Endocytosis of liposomes bound to cell surface proteins measured by flow cytofluorometry.
Biochem J. 1983 Jul 15;214(1):189-94
PMID: 6615464
-
Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.
Proc Natl Acad Sci U S A. 1986 May;83(9):2787-91
PMID: 3010316
-
Inhibition of vesicular stomatitis virus protein synthesis and infection by sequence-specific oligodeoxyribonucleoside methylphosphonates.
Biochemistry. 1986 Oct 7;25(20):6268-75
PMID: 3024704
-
Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site.
Proc Natl Acad Sci U S A. 1987 Feb;84(3):648-52
PMID: 3027696
-
A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
Nature. 1987 Jul 30-Aug 5;328(6129):445-9
PMID: 3302722
-
Major histocompatibility complex class I molecules internalized via coated pits in T lymphocytes.
Nature. 1987 Aug 20-26;328(6132):724-6
PMID: 2886920
-
Endocytosis and de novo expression of major histocompatibility complex encoded class I molecules: kinetic and ultrastructural studies.
Eur J Cell Biol. 1987 Dec;45(1):126-36
PMID: 3443107
-
Inhibition of human immunodeficiency virus by using an oligonucleoside methylphosphonate targeted to the tat-3 gene.
J Virol. 1988 Oct;62(10):3914-7
PMID: 2458490
-
Antiviral activity of conjugates between poly(L-lysine) and synthetic oligodeoxyribonucleotides.
Gene. 1988 Dec 10;72(1-2):323-32
PMID: 2854089
-
Antibody targeted liposomes containing poly(rI).poly(rC) exert a specific antiviral and toxic effect on cells primed with interferons alpha/beta or gamma.
Biochim Biophys Acta. 1989 Dec 11;987(1):15-20
PMID: 2557080
-
Modulation of eukaryotic gene expression by complementary RNA or DNA sequences.
Biotechniques. 1988 Nov-Dec;6(10):958-76
PMID: 2483657
-
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature. 1970 Aug 15;227(5259):680-5
PMID: 5432063
-
Fluorographic detection of radioactivity in polyacrylamide gels with the water-soluble fluor, sodium salicylate.
Anal Biochem. 1979 Sep 15;98(1):132-5
PMID: 543547
-
Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A.
Nature. 1980 Dec 11;288(5791):602-4
PMID: 7442804
-
Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus N and NS proteins.
J Virol. 1981 Aug;39(2):529-35
PMID: 6268841
-
Drug transfer into lymphoblasts mediated by liposomes bound to distinct sites on H-2 encoded I-A, I-E, and K molecules.
J Immunol. 1982 Nov;129(5):2098-102
PMID: 6811657
-
Small liposomes are better than large liposomes for specific drug delivery in vitro.
Biochim Biophys Acta. 1983 May 5;730(2):313-20
PMID: 6849906
-
Antiviral activity in L1210 cells of liposome-encapsulated (2'-5')oligo(adenylate) analogues.
Eur J Biochem. 1985 Sep 2;151(2):319-25
PMID: 2992962